Literature DB >> 803415

Suppression and augmentation of the primary in vitro immune response by different classes of antibodies.

J Gordon, R A Murgita.   

Abstract

Mesh：

Substances：

Year:  1975        PMID： 803415     DOI： 10.1016/0008-8749(75)90017-9

Source DB:  PubMed          Journal:  Cell Immunol        ISSN： 0008-8749            Impact factor:   4.868


× No keyword cloud information.
  12 in total

1.  Direct blockade of antigen-reactive B lymphocytes by immune complexes. An 'off' signal for precursors of IgM-producing cells provided by the linkage of antigen-and Fc-receptors.

Authors:  J Oberbarnscheidt; E Kölsch
Journal:  Immunology       Date:  1978-07       Impact factor: 7.397

2.  Regulation of IgG antibody synthesis by a B cell component.

Authors:  M Hinchman; J R Battisto
Journal:  Immunology       Date:  1977-11       Impact factor: 7.397

3.  Marked enhancement in vivo of adjuvant activity of muramyl dipeptide to protein antigens and to synthetic weak immunogens with monoclonal anti-muramyl dipeptide antibodies.

Authors:  G M Bahr; D S Tello; L A Chedid
Journal:  Infect Immun       Date:  1985-08       Impact factor: 3.441

4.  Inhibitory mechanism of the proliferative response of B lymphocytes: suppression of the proliferation induced by anti-mu antibody and BSF1 by immune complexes.

Authors:  M Miyama-Inaba; T Ohno; K Inaba; K Ajisaka; R Suzuki; K Kumagai; T Masuda
Journal:  Immunology       Date:  1987-05       Impact factor: 7.397

5.  Generation of memory cells. III. Antibody class requirements for the generation of B-memory cells by antigen--antibody complexes.

Authors:  G G Klaus
Journal:  Immunology       Date:  1979-06       Impact factor: 7.397

6.  Escape from antibody-mediated immune suppression in vitro by delayed-type hypersensitivity reaction.

Authors:  C C Muscoplat; T M Setcavage; Y B Kim
Journal:  Infect Immun       Date:  1977-02       Impact factor: 3.441

7.  Lack of IgA subclass restriction in antibody response to phosphorylcholine, beta lactoglobulin and tetanus toxoid.

Authors:  M E Conley; D E Briles
Journal:  Immunology       Date:  1984-11       Impact factor: 7.397

8.  Control of B-lymphocyte function. I. Inactivation of mitogenesis by interactions with surface immunoglobulin and Fc-receptor molecules.

Authors:  C L Sidman; E R Unanue
Journal:  J Exp Med       Date:  1976-10-01       Impact factor: 14.307

9.  B-lymphocytes activation by the Fc region of IgG.

Authors:  M A Berman; W O Weigle
Journal:  J Exp Med       Date:  1977-07-01       Impact factor: 14.307

10.  Isoantiserum-augmented development of lymphocyte-mediated cytotoxicity.

Authors:  R Faanes; M Walker; Y S Choi
Journal:  J Exp Med       Date:  1976-11-02       Impact factor: 14.307
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.